Literature DB >> 30363927

Treatment of Involuntary Movements with Carbamazepine in Dystonic-Choreoathetoid Cerebral Palsy.

Shyamal H Mehta1, Inder M Sawhney2, Kathir Yoganathan3, Jill P Trumble4, John C Morgan4, Kapil D Sethi4.   

Abstract

Choreoathetoid movements are quite common in cerebral palsy (CP). This is the first report of a patient with choreoathetoid CP who was successfully treated with carbamazepine. Therefore, clinicians should try carbamazepine for involuntary movements in CP patients before pursuing other procudures.

Entities:  

Keywords:  carbamazepine; cerebral palsy; dyskinetic cerebral palsy; dystonic‐choreoathetoid cerebral palsy; levetiracetam

Year:  2014        PMID： 30363927      PMCID： PMC6183257          DOI： 10.1002/mdc3.12002

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


  5 in total

1.  Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE).

Authors: 
Journal:  Dev Med Child Neurol       Date:  2000-12       Impact factor: 5.449

2.  Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy.

Authors:  A H Hoon; P O Freese; E M Reinhardt; M A Wilson; W T Lawrie; S E Harryman; F S Pidcock; M V Johnston
Journal:  Pediatr Neurol       Date:  2001-07       Impact factor: 3.372

Review 3.  Cerebral palsy.

Authors:  L Andrew Koman; Beth Paterson Smith; Jeffrey S Shilt
Journal:  Lancet       Date:  2004-05-15       Impact factor: 79.321

4.  Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy.

Authors:  G F Vles; J G Hendriksen; A Visschers; L Speth; J Nicolai; J S H Vles
Journal:  Dev Med Child Neurol       Date:  2008-11-19       Impact factor: 5.449

5.  Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study.

Authors:  Marie Vidailhet; Jerome Yelnik; Christelle Lagrange; Valerie Fraix; David Grabli; Stephane Thobois; Pierre Burbaud; Marie-Laure Welter; Jin Xie-Brustolin; Maria-Clara Coelho Braga; Claire Ardouin; Virginie Czernecki; Hélène Klinger; Stephan Chabardes; Eric Seigneuret; Patrick Mertens; Emmanuel Cuny; Soledad Navarro; Philippe Cornu; Alim-Louis Benabid; Jean-Francois Le Bas; Didier Dormont; Marc Hermier; Kathy Dujardin; Serge Blond; Pierre Krystkowiak; Alain Destée; Eric Bardinet; Yves Agid; Paul Krack; Emmanuel Broussolle; Pierre Pollak
Journal:  Lancet Neurol       Date:  2009-07-01       Impact factor: 44.182
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.